Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. - Wikidata - thesis-toulmin - TriplyDB

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

http://www.wikidata.org/entity/Q34292807

about

Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF Anti-vascular endothelial growth factor for neovascular age-related macular degeneration Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathologic myopia Anti-vascular endothelial growth factor for neovascular glaucoma Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration Interferon alfa therapy for age-related macular degeneration Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth Retinal vein occlusion: pathophysiology and treatment options Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis Endothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor.Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration The Vitreomacular Interface in Diabetic Retinopathy Anti-VEGF Therapy and the Retina: An Update Microvascular complications and diabetic retinopathy: recent advances and future implications Functions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathy Clinical development of new treatments for diabetic macular oedema Current management of vitreous hemorrhage due to proliferative diabetic retinopathy Oxygen sensing in retinal health and disease Targeting inflammation in diabetes: Newer therapeutic options Challenges in elucidating the genetics of diabetic retinopathy Mechanisms of age-related macular degeneration Novel pharmacotherapies in diabetic retinopathy Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration Alternative pathways in the development of diabetic retinopathy: the renin-angiotensin and kallikrein-kinin systems A review of anti-VEGF agents for proliferative diabetic retinopathy Vitreous mediators in retinal hypoxic diseases Total Chemical Synthesis of Biologically Active Vascular Endothelial Growth Factor Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site Neovascular glaucoma: a review Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy ERK5 Mediated Signalling in Diabetic Retinopathy

P2860

Q22008806-CD9A69BB-E499-41F2-9E61-649569B66F41 Q22253478-1E086FB4-D364-4CBD-86B6-37EDC3B878CE Q24194251-ED54FD9D-C86D-4478-B79D-D4C5388C86E5 Q24194332-54EB6691-B49A-4D71-BFDA-4E5E84035276 Q24197589-9D282350-C4D9-4CEA-858F-9C3714B9766A Q24243234-CD903197-3389-4DE5-AD9C-07BE03FFB545 Q24244534-7EAE44F0-C73C-4AAE-A933-4F2EF3B8B427 Q24245483-11D320D6-6997-4454-B25C-FDB4F1A414B1 Q24246549-83B24535-9B5B-4F07-B1D5-722CF08BCBC8 Q24531302-F95F30C5-441C-4A69-83EA-DD4A8FDEB0FC Q24561921-D5F2442A-A8EA-434F-ADB5-F5854799AFBA Q24596993-8A06F089-5DBF-4BC5-80BF-B11ED2D13BE2 Q24628949-BAE5A9F9-45FC-4E87-A10B-E79601140B2E Q24652148-97621A1C-E8DA-4A40-B13C-F92A792C1957 Q24816272-67A10126-7550-4DB5-B9F2-D7D94963CB90 Q26750459-3D5F045F-502C-4F0B-A123-0B1FDD92630A Q26772889-49A46405-1C80-43E5-99D5-0C173DBF9FF7 Q26775853-BB337C70-A924-4D62-B83E-6F6DA2BE12BD Q26783389-2F6CEE72-3D32-49BD-9335-89078BDA6C6D Q26783404-BA7FF143-FA23-43F0-8E0B-38F512B02648 Q26784605-EAE1ED49-BEC5-4DA6-8A76-E3448CCF6B66 Q26822476-59A3117C-F43D-4C75-AC18-85BE8F32E322 Q26824541-70425FC7-0349-4560-A939-8AEDA8502724 Q26825365-A1F62BAA-6999-426F-ADA0-3B450D4E3D96 Q26827302-5130E814-907E-46CF-9EE1-0FA22EE26437 Q26827518-29A7DF9B-CAB6-45D8-95DD-A09BC5C5DF85 Q26852726-F6CF4857-3E11-45FF-B4FF-E65E805F9411 Q26998699-0529CC73-8FB8-464F-93C0-F3D7E820B498 Q27000182-A1AD227C-C80B-40E3-B787-1493A1E15819 Q27002622-A51002F3-2D81-432C-AA7D-1DF3BD2D8546 Q27015781-8FC2FB78-B31B-4B46-89EA-70BC90BE55FB Q27025635-CE5BDC42-C24D-4E85-8DB6-6F7224868831 Q27025643-6B2D581A-0AA4-461E-A8A2-2F4BD5E1B285 Q27028225-4EC0BB97-C693-45DC-9109-C9369B0AFB13 Q27670754-20DF9493-306E-4802-86C8-18E2CB114D33 Q27740067-CD0A8CF4-7A2E-4A03-9C1D-1F7EA82E84E8 Q28067262-651260E0-5C1F-4232-B844-A2AB9D7C4BEF Q28075473-C791A1A7-E2FD-4B17-98EB-5304D21337A7 Q28078199-04CA35A5-09AB-4B2C-804C-C9265BD84792 Q28083251-DEBCC0E9-B594-430F-B030-4BAD814AA7EF

P2860

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

http://www.wikidata.org/entity/Q34292807

description

1994 nî lūn-bûn

@nan

1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Vascular endothelial growth fa ...... y and other retinal disorders.

@ast

Vascular endothelial growth fa ...... y and other retinal disorders.

@en

Vascular endothelial growth fa ...... y and other retinal disorders.

@nl

type

label

Vascular endothelial growth fa ...... y and other retinal disorders.

@ast

Vascular endothelial growth fa ...... y and other retinal disorders.

@en

Vascular endothelial growth fa ...... y and other retinal disorders.

@nl

prefLabel

Vascular endothelial growth fa ...... y and other retinal disorders.

@ast

Vascular endothelial growth fa ...... y and other retinal disorders.

@en

Vascular endothelial growth fa ...... y and other retinal disorders.

@nl

P1433

Q34292807-A6245166-73B2-4D2E-9212-FB9971E302EA

P1476

Q34292807-0A8E4059-08F1-4C6D-988C-AB731774532A

P2093

Q34292807-3AD2D842-19E3-40B2-BAB3-685A25029CA9

Q34292807-4042EFB3-E339-4512-8414-E3BE8DE1C56D

Q34292807-4B27A115-867B-43E3-AF62-B883717B850B

Q34292807-4C344448-E15B-4444-9EB9-B9F3312D6DE9

Q34292807-500254DA-5EBA-489F-8978-5373BF31001D

Q34292807-515464D5-F86C-48A6-B675-864B0EC3C606

Q34292807-72090B5C-89B9-404D-A50F-BA260C3217D3

Q34292807-9D4E6F2E-A92D-4C34-827C-8FB811651842

Q34292807-EF6D58BD-B681-47B8-824E-F567214246B7

Q34292807-F8EA1762-ECA0-4568-A5D7-9BDC5096D1EB

P304

Q34292807-7E05374A-D3C0-4A8C-9F51-0EC239CF052D

P31

Q34292807-0206986C-CBB1-424A-948F-A3673F615606

P356

Q34292807-ED2B7B66-256E-4F2A-BAA9-AF94336C465C

P407

Q34292807-FC04374F-C4FA-4CFC-800B-DF736B307458

P433

Q34292807-67268AA9-C010-4C9A-9166-5E7EA79571E7

P478

Q34292807-3B238F3C-C4EC-4470-9AFE-7ACAD2B31666

P577

Q34292807-20DCB3D6-8D41-445C-BD60-FFB3DAEC4869

P698

Q34292807-5CBCAE8A-E50E-4B51-970C-766F4DF4A590

P921

Q34292807-58B2D7D6-40ED-4DF1-AF19-1315096CB4A5

Q34292807-B4062242-BD82-4FA3-A3C4-BBA6C4D3DBE8

P356

NEJM199412013312203

P1433

The New England Journal of Medicine

P1476

Vascular endothelial growth fa ...... y and other retinal disorders.

@en

P2093

Aiello LP

http://www.w3.org/2001/XMLSchema#string

Arrigg PG

http://www.w3.org/2001/XMLSchema#string

Avery RL

http://www.w3.org/2001/XMLSchema#string

Iwamoto MA

http://www.w3.org/2001/XMLSchema#string

Jampel HD

http://www.w3.org/2001/XMLSchema#string

Keyt BA

http://www.w3.org/2001/XMLSchema#string

Park JE

http://www.w3.org/2001/XMLSchema#string

Pasquale LR

http://www.w3.org/2001/XMLSchema#string

Shah ST

http://www.w3.org/2001/XMLSchema#string

Thieme H

http://www.w3.org/2001/XMLSchema#string

P304

1480-1487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199412013312203

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

331

http://www.w3.org/2001/XMLSchema#string

P577

1994-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7526212

http://www.w3.org/2001/XMLSchema#string

P921